S1 File - Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment

Combined Supporting Information file. Figure S1, The IHC result of monoclonal IgG Isotype Control on human pancreatic adenocarcinoma tissues by immunoperoxidase and immunofluorescence methods, respectively. Figure S2, CD90 expression in the adjacent normal tissue (ANT) of pancreatic adenocarcinoma. Figure S3, CD90 expression in benign islet cell tumors. Figure S4, Expression of CD90 (green) in mtastatic pancreatic adenocarcinoma to liver, lymph node, abdominal cavity, and omentum, respectively. Figure S5, Expression of CD90 (green) in malignant pancreatic neuroendocrine tumor and adenosquamous carcinoma. Figure S6, A representative set of images showing the colocalization of collagen, CD90 (green) and αSMA (red) staining in stromal area of PDAC. Figure S7, Coexpression of CD90 (green) and CD31 (red) in pancreatic neuroendocrine tumor. Figure S8, Double immunofluorescence staining of CD90 (green) and CD45 (red) in chronic pancreatitis and pancreatic adenocarcinoma of early (I and II) and late (III and IV) stages. (PDF)